Cortellis

Cortellis
Name	Cortellis
Industry	Biotechnology information services
Founded	1990s
Headquarters	United Kingdom / United States
Owner	Clarivate
Products	Drug intelligence, regulatory intelligence, clinical trial intelligence

Cortellis is a commercial suite of life sciences intelligence products providing integrated information for drug discovery, clinical development, regulatory affairs, and commercial strategy. It aggregates bibliographic, patent, clinical, regulatory, and transactional intelligence to support decision-making for pharmaceutical companies, biotechnology firms, contract research organizations, and academic translational centers. The platform is maintained as part of a global information and analytics portfolio aimed at accelerating timelines across discovery-to-market pathways.

Overview

Cortellis offers curated datasets, workflow tools, and analytics linking sources such as Food and Drug Administration, European Medicines Agency, ClinicalTrials.gov, World Health Organization, and proprietary indexing from major publishers. Its user base spans stakeholders at Pfizer, GlaxoSmithKline, Roche, Novartis, and Johnson & Johnson as well as government agencies like National Institutes of Health and research institutions such as Johns Hopkins University. By combining patent documents from offices like the United States Patent and Trademark Office and European Patent Office with peer-reviewed literature indexed by Nature Publishing Group and Elsevier, the product supports cross-domain queries for target validation, cohort selection, and competitive landscaping.

History and Development

The product lineage traces to specialized pharmaceutical databases developed in the late 1990s and early 2000s by commercial information providers that later consolidated under multinational publishers. Major events in its evolution include mergers and acquisitions involving companies tied to bibliographic services, patent intelligence, and regulatory content used by organizations such as Thomson Reuters and Reed Elsevier. Clarivate acquired a suite of life sciences assets from established information conglomerates and integrated them with citation indexes like Web of Science to create a combined offering. Strategic expansions mirrored industry trends triggered by large-scale initiatives at Biogen, Merck & Co., AstraZeneca, and regulatory modernization programs at European Commission agencies.

Products and Services

The platform provides modules for drug pipelines, target profiles, mechanism-of-action summaries, clinical trial tracking, and regulatory milestones. Commercially relevant outputs include market exclusivity timelines used by teams at Bristol-Myers Squibb, forecasting groups relying on models similar to those published by IMS Health (now IQVIA), and safety surveillance signals cross-referenced with databases maintained by Centers for Disease Control and Prevention and European Centre for Disease Prevention and Control. Services support lifecycle management for biologics and small molecules, competitive intelligence employed by corporate strategy units at Sanofi and Eli Lilly and Company, and licensing diligence undertaken alongside legal teams referencing decisions from courts such as the United States Court of Appeals for the Federal Circuit.

Technology and Data Sources

Cortellis integrates text-mining, natural language processing, and ontology mapping drawing on named-entity recognition frameworks used in projects at Massachusetts Institute of Technology and Stanford University. Data sources include regulatory dossiers from Food and Drug Administration approvals, clinical registry entries from ClinicalTrials.gov, patent families from the World Intellectual Property Organization, and bibliographic metadata from publishers like Springer Nature and Wiley-Blackwell. Analytical layers include visualization components for network diagrams paralleling approaches in network pharmacology research from Harvard Medical School and cheminformatics tools informed by standards from International Union of Pure and Applied Chemistry. The platform supports API access for integration with enterprise systems deployed at multinational firms such as Oracle and SAP.

Industry Impact and Applications

Life sciences organizations use the intelligence for target prioritization, competitive scouting, portfolio optimization, and regulatory strategy alignment. Translational research centers at institutions like University of California, San Francisco and Cambridge Biomedical Campus leverage such integrated datasets to accelerate bench-to-bedside programs and to design adaptive clinical trials—approaches exemplified in studies at Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center. Regulatory affairs teams apply insights to prepare dossiers in alignment with guidance from International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, while commercial teams map launch sequencing informed by payer landscapes shaped in part by decisions from entities such as Centers for Medicare & Medicaid Services.

Partnerships and Acquisitions

The platform’s capabilities have been expanded through alliances with content providers, data aggregators, and technology vendors. Historical collaborations reflect engagements with major publishers including Elsevier, Thomson Reuters-era assets, and partnerships with analytics firms that service clients like IQVIA and McKinsey & Company. Corporate ownership transitions involved transactions by private equity and strategic buyers within the information industry, aligning the product with Clarivate’s family of services including citation indexes and patent analytics. Integration projects frequently cite interoperability with laboratory information management systems used in companies such as Thermo Fisher Scientific and contract research organizations like Covance.

Category:Biotechnology databases